Entyvio is a biologic medication containing Vedolizumab, used for the treatment of moderate to severe inflammatory bowel diseases such as ulcerative colitis and Crohn’s disease. It works by selectively reducing inflammation in the gastrointestinal tract and helping improve symptoms.
Indications
-
Treatment of moderate to severe ulcerative colitis
-
Treatment of moderate to severe Crohn’s disease
-
Helps reduce intestinal inflammation
-
Helps improve digestive symptoms
Directions for Use
Administered by intravenous infusion in a hospital or clinical setting under specialist supervision.
Warnings
-
Prescription medicine – medical supervision required
-
May increase risk of infections
-
Inform your doctor if you have active infections or immune disorders
-
Consult your doctor if pregnant or breastfeeding
-
Keep out of reach of children
Reviews
There are no reviews yet.